MacroGenics (MGNX) shares crossed the average analyst 12-month target of $3.40, trading at $3.43 (≈+0.9% above the target). This is a marginal, technical development that may prompt analysts to revise ratings or targets; watch for any near-term analyst notes that could move the stock.
MacroGenics (MGNX) shares crossed the average analyst 12-month target of $3.40, trading at $3.43 (≈+0.9% above the target). This is a marginal, technical development that may prompt analysts to revise ratings or targets; watch for any near-term analyst notes that could move the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
